In the clinical setting, most observational studies showed low OPG concentrations in metabolically healthy obesity and NAFLD, whereas high concentrations in T2DM, in which higher OPG was also associated with the severity of disease and diabetic complications. The gene discussed is TNFRSF11B; the disease is type 2 diabetes mellitus.